These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 6552855)
61. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. Pixley RA; De La Cadena R; Page JD; Kaufman N; Wyshock EG; Chang A; Taylor FB; Colman RW J Clin Invest; 1993 Jan; 91(1):61-8. PubMed ID: 7678610 [TBL] [Abstract][Full Text] [Related]
62. Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12. Bhattacharjee G; Revenko AS; Crosby JR; May C; Gao D; Zhao C; Monia BP; MacLeod AR Nucleic Acid Ther; 2013 Jun; 23(3):175-87. PubMed ID: 23582057 [TBL] [Abstract][Full Text] [Related]
63. [Relationship among coagulation, fibrinolysis, kinin formation and factor XII]. Saito H Rinsho Ketsueki; 1978 Jun; 19(6):785-91. PubMed ID: 713043 [No Abstract] [Full Text] [Related]
66. Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein. Shibayama Y; Joseph K; Nakazawa Y; Ghebreihiwet B; Peerschke EI; Kaplan AP Clin Immunol; 1999 Jan; 90(1):89-99. PubMed ID: 9884356 [TBL] [Abstract][Full Text] [Related]
67. [Test for dynamic evaluation of plasma kininogenic activity]. Malofiejew M; Kulesza JB Pol Arch Med Wewn; 1976 Jan; 55(1):33-43. PubMed ID: 1250733 [No Abstract] [Full Text] [Related]
68. Interaction of the clotting, kinin-forming, complement, and fibrinolytic pathways in inflammation. Kaplan AP; Silverberg M; Dunn JT; Ghebrehiwet B Ann N Y Acad Sci; 1982; 389():25-38. PubMed ID: 7046578 [No Abstract] [Full Text] [Related]
69. Kinin-prekallikrein system in Mediterranean spotted fever. Vicente V; Alegre A; Ruiz R; Herrero JI; Portugal J; Alberca I J Infect Dis; 1986 Sep; 154(3):541. PubMed ID: 3637203 [No Abstract] [Full Text] [Related]
70. The kinin system and its relations to other systems. Movat HZ Curr Top Pathol; 1979; 68():111-34. PubMed ID: 158491 [No Abstract] [Full Text] [Related]
71. Activators of inactive renin ("prorenin') in human plasma: their connection with kinin formation, coagulation and fibrinolysis. Derkx FH; Bouma BN; Tan-Tjiong HL; Schalekamp MA Clin Sci (Lond); 1979 Dec; 57 Suppl 5():89s-92s. PubMed ID: 396095 [No Abstract] [Full Text] [Related]
73. A study of hemostasis in ischemic cerebrovascular disease: IV. A five year follow-up of some blood coagulation parameters also including fibrinopeptide A, factor XII and prekallikrein. Mettinger KL Thromb Res; 1982 Jul; 27(2):155-60. PubMed ID: 6814002 [TBL] [Abstract][Full Text] [Related]
74. The coagulation-kinin pathway of human plasma. Kaplan AP; Silverberg M Blood; 1987 Jul; 70(1):1-15. PubMed ID: 3297198 [No Abstract] [Full Text] [Related]
75. A biochemical study on the kinetics of kininogen in asphyxiated newborn. Suzuki S Adv Exp Med Biol; 1983; 156 (Pt B)():1067-75. PubMed ID: 6858761 [No Abstract] [Full Text] [Related]
76. The influence of drugs on the kinin-forming system in relation to pregnancy and parturition in the rat. Senior J; Whalley ET J Reprod Fertil; 1976 Jul; 47(2):319-23. PubMed ID: 1085366 [TBL] [Abstract][Full Text] [Related]
77. Tissue kallikreins and kinins: roles in human disease and target for new drug development. Margolius HS Adv Exp Med Biol; 1989; 247A():1-6. PubMed ID: 2690583 [TBL] [Abstract][Full Text] [Related]
78. On the endogenous mechanism of kinin release. II. Attempts at discriminating kininogens. Habermann E; Jahrreiss R Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(1):101-11. PubMed ID: 4252437 [No Abstract] [Full Text] [Related]
79. The role of kallikrein in leukocyte migration inhibition. Sultan AM; Dunn CJ; Willoughby DA Inflammation; 1979 Jul; 3(3):295-303. PubMed ID: 314418 [TBL] [Abstract][Full Text] [Related]